U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Description
Curator's Comment: description was created based on several sources, including https://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/SCOGS/ucm260884.htm | http://www.webmd.com/drugs/2/drug-159847/calcium-phosphate-dibasic-oral/details

Anhydrous dibasic calcium phosphate is a calcium salt of phosphoric acid. It is used as a diluent in pharmaceutical industry, in some toothpastes as a polishing agent. Calcium phosphate is generally recognized as safe by FDA. Dibasic calcium phosphate is ised as a supplement to treat conditions associated with calcium deficit, such as bone loss (osteoporosis), weak bones (osteomalacia/rickets), decreased activity of the parathyroid gland (hypoparathyroidism), and a certain muscle disease (latent tetany)

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Palliative
Unknown

Approved Use

Unknown
Palliative
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Hypocalcemia, chronic (treatment) ā€” Oral calcium supplements provide a source of calcium ion for treating calcium depletion occurring in conditions such as chronic hypoparathyroidism, pseudohypoparathyroidism, osteomalacia, rickets, chronic renal failure, and hypocalcemia secondary to the administration of anticonvulsant medications. When chronic hypocalcemia is due to vitamin D deficiency, oral calcium salts may be administered concomitantly with vitamin D analogs. However, calcium phosphate should not be used in patients with hypoparathyroidism or renal failure, since phosphate levels may be too high and giving more phosphate would exacerbate the condition. Calcium supplements should not be used in hyperparathyroidism, unless the need for a calcium supplement is high and the patient is carefully monitored. For treatment of hypocalcemia, supplementation is preferred
PubMed

PubMed

TitleDatePubMed
Effects of terbutaline on force and intracellular calcium in slow-twitch skeletal muscle fibres of the rat.
1999 Apr
[Early stage of cardiomyopathy: mechanisms of damage and compensation].
1999 Jul
C-reactive protein in the hemolymph of Achatina fulica: interrelationship with sex steroids and metallothionein.
2000 Apr
Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist.
2000 Dec
Regulation of LPA-promoted myofibroblast contraction: role of Rho, myosin light chain kinase, and myosin light chain phosphatase.
2000 Feb 1
Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells.
2000 Jan 7
Effects of a calcimimetic compound and naturally activating mutations on the human Ca2+ receptor and on Ca2+ receptor/metabotropic glutamate chimeric receptors.
2000 Nov
Pharmacological blockade of ERG K(+) channels and Ca(2+) influx through store-operated channels exerts opposite effects on intracellular Ca(2+) oscillations in pituitary GH(3) cells.
2000 Nov
Mechanism of extracellular calcium regulation of intestinal epithelial tight junction permeability: role of cytoskeletal involvement.
2000 Oct 15
ATP induces dephosphorylation of myosin light chain in endothelial cells.
2000 Sep
Expression and functional analysis of chemokine receptors in human peripheral blood leukocyte populations.
2001 Apr 7
Molecular and functional characterization of a family of rat brain T-type calcium channels.
2001 Feb 9
Analysis of the native quaternary structure of vanilloid receptor 1.
2001 Jul 27
Mechanisms of regulation of agonist efficacy at the 5-HT(1A) receptor by phospholipid-derived signaling components.
2001 Jun
Long-term alteration of calcium homeostatic mechanisms in the pilocarpine model of temporal lobe epilepsy.
2001 Jun 8
Regional differences in functional receptor distribution and calcium mobilization in the intact human lens.
2001 Sep
The role of endogenous human Trp4 in regulating carbachol-induced calcium oscillations in HEK-293 cells.
2002 Apr 19
Interaction of intravenous anesthetics with recombinant human M1-M3 muscarinic receptors expressed in chinese hamster ovary cells.
2002 Dec
Characterization of the bone-resorptive effect of interleukin-11 in cultured mouse calvarial bones.
2002 Jul
Investigation of a functional requirement for isoprenylation by the human prostacyclin receptor.
2002 Mar
Mechanism of enhanced calcium sensitivity and alpha 2-AR vasoreactivity in chronic NOS inhibition hypertension.
2003 Jan
[Prevention of osteoporosis by foods and dietary supplements. Bioavailability of milk micellar calcium phosphate].
2006 Oct
Effect of calcium phosphate and vitamin Dā‚ƒ supplementation on bone remodelling and metabolism of calcium, phosphorus, magnesium and iron.
2014 Jan 17
Effects of ultrasound treatment on physico-chemical, functional properties and antioxidant activity of whey protein isolate in the presence of calcium lactate.
2018 Mar
Patents

Sample Use Guides

oral: 500 to 2000 mg elemental calcium a day, in divided doses (bid-qid). inhalation: In a single-blind, phase 1B proof of concept study, 24 subjects were enrolled to sequentially receive three doses of PUR118 (calcium lactate inhalation powder (CLIP) formulation) (5.5 mg, n = 18; 11.0 mg, n = 18; 2.8 mg, n = 16). Each dose was inhaled 3 times (1, 13, 25 h, preceded by 2 puffs salbutamol) before the ozone exposure (250 ppb, 3 h intermittent exercise). Sputum was induced 3 h after the end of exposure.
Route of Administration: Other
In Vitro Use Guide
Unknown
Name Type Language
CALCIUM PHOSPHATE
EP   II   INCI   MART.   VANDF   WHO-DD  
INCI  
Preferred Name English
CALCIUM PHOSPHATE, UNSPECIFIED FORM
Common Name English
CALCIUM PHOSPHATE [VANDF]
Common Name English
CALCIUM PHOSPHATE [INCI]
Common Name English
CALCIUM PHOSPHATE [II]
Common Name English
CALCIUM PHOSPHATE [EP IMPURITY]
Common Name English
CALCIUM PHOSPHATE [MART.]
Common Name English
PHOSPHORIC ACID, CALCIUM SALT
Common Name English
TRICALCII PHOSPHAS
Common Name English
CALCIUM PHOSPHATE [EP MONOGRAPH]
Common Name English
Classification Tree Code System Code
CFR 21 CFR 331.15
Created by admin on Fri Dec 15 16:04:19 GMT 2023 , Edited by admin on Fri Dec 15 16:04:19 GMT 2023
WHO-VATC QA12AA01
Created by admin on Fri Dec 15 16:04:19 GMT 2023 , Edited by admin on Fri Dec 15 16:04:19 GMT 2023
CFR 21 CFR 331.11
Created by admin on Fri Dec 15 16:04:19 GMT 2023 , Edited by admin on Fri Dec 15 16:04:19 GMT 2023
EPA PESTICIDE CODE 76401
Created by admin on Fri Dec 15 16:04:19 GMT 2023 , Edited by admin on Fri Dec 15 16:04:19 GMT 2023
WHO-ATC A12AA01
Created by admin on Fri Dec 15 16:04:19 GMT 2023 , Edited by admin on Fri Dec 15 16:04:19 GMT 2023
LOINC 32137-2
Created by admin on Fri Dec 15 16:04:19 GMT 2023 , Edited by admin on Fri Dec 15 16:04:19 GMT 2023
Code System Code Type Description
EVMPD
SUB127040
Created by admin on Fri Dec 15 16:04:19 GMT 2023 , Edited by admin on Fri Dec 15 16:04:19 GMT 2023
ALTERNATIVE
NCI_THESAURUS
C45678
Created by admin on Fri Dec 15 16:04:19 GMT 2023 , Edited by admin on Fri Dec 15 16:04:19 GMT 2023
CONCEPT Industrial Aid
RXCUI
1919
Created by admin on Fri Dec 15 16:04:19 GMT 2023 , Edited by admin on Fri Dec 15 16:04:19 GMT 2023
PRIMARY RxNorm
FDA UNII
97Z1WI3NDX
Created by admin on Fri Dec 15 16:04:19 GMT 2023 , Edited by admin on Fri Dec 15 16:04:19 GMT 2023
PRIMARY
CHEBI
9679
Created by admin on Fri Dec 15 16:04:19 GMT 2023 , Edited by admin on Fri Dec 15 16:04:19 GMT 2023
PRIMARY
CAS
10103-46-5
Created by admin on Fri Dec 15 16:04:19 GMT 2023 , Edited by admin on Fri Dec 15 16:04:19 GMT 2023
NON-SPECIFIC STOICHIOMETRY
DAILYMED
97Z1WI3NDX
Created by admin on Fri Dec 15 16:04:19 GMT 2023 , Edited by admin on Fri Dec 15 16:04:19 GMT 2023
PRIMARY
EVMPD
SUB127041
Created by admin on Fri Dec 15 16:04:19 GMT 2023 , Edited by admin on Fri Dec 15 16:04:19 GMT 2023
ALTERNATIVE
NCI_THESAURUS
C120560
Created by admin on Fri Dec 15 16:04:19 GMT 2023 , Edited by admin on Fri Dec 15 16:04:19 GMT 2023
PRIMARY
SMS_ID
100000088337
Created by admin on Fri Dec 15 16:04:19 GMT 2023 , Edited by admin on Fri Dec 15 16:04:19 GMT 2023
PRIMARY
MESH
C020243
Created by admin on Fri Dec 15 16:04:19 GMT 2023 , Edited by admin on Fri Dec 15 16:04:19 GMT 2023
PRIMARY
EVMPD
SUB20364
Created by admin on Fri Dec 15 16:04:19 GMT 2023 , Edited by admin on Fri Dec 15 16:04:19 GMT 2023
PRIMARY
ECHA (EC/EINECS)
233-283-6
Created by admin on Fri Dec 15 16:04:19 GMT 2023 , Edited by admin on Fri Dec 15 16:04:19 GMT 2023
PRIMARY
DRUG CENTRAL
4441
Created by admin on Fri Dec 15 16:04:19 GMT 2023 , Edited by admin on Fri Dec 15 16:04:19 GMT 2023
PRIMARY
EVMPD
SUB127042
Created by admin on Fri Dec 15 16:04:19 GMT 2023 , Edited by admin on Fri Dec 15 16:04:19 GMT 2023
ALTERNATIVE
DRUG BANK
DB11348
Created by admin on Fri Dec 15 16:04:19 GMT 2023 , Edited by admin on Fri Dec 15 16:04:19 GMT 2023
PRIMARY
EPA CompTox
DTXSID40893099
Created by admin on Fri Dec 15 16:04:19 GMT 2023 , Edited by admin on Fri Dec 15 16:04:19 GMT 2023
PRIMARY
Definition References